Researchers have developed a new model to study neurodegenerative diseases which affect motor neurons, such as ALS.
A new study reports high cholesterol may contribute to the risk of developing ALS. The findings suggest cholesterol lowering drugs, such as statins, could help to prevent the onsite of the neurodegenerative disease.
Researchers have identified a causal link between strenuous exercise and ALS in people with genetic risk factors for the neurodegenerative disease. The study reports intense physical exercise contributes to motor neuron injury in those susceptible to ALS.
Researchers have discovered a potential treatment that may help delay motor neuron loss in ALS.
Researchers believe a newly discovered mechanism may contribute to cell death in people suffering from ALS and dementia.
An examination of brainstems from children and young adults constantly exposed to air pollution reveals markers of Alzheimer's disease, Parkinson's disease, and motor neuron disease. Findings suggest air pollution poses risks of serious neurological damage from an early age.
New research could help find a solution to slowing down the progression of motor neuron disease.
According to researchers, astrocytes lose the ability to support motor neurons as ALS progresses.
Terazosin, a drug commonly prescribed for the treatment of enlarged prostate and high blood pressure, shows promise as a treatment for ALS.
A new study reports that abnormalities in the SOD1 protein are a common factor in all types of motor neuron diseases.
Proteins associated with motor neuron disease, or ALS are present in the gut many years before disease pathologies can be found in the brain. A stool sample or gut biopsy could help identify the presence of MND-associated proteins years before symptoms appear.
